Carl Zeiss Meditec (ETR:AFX) Stock Price Down 0.5% – Should You Sell?

Carl Zeiss Meditec AG (ETR:AFXGet Free Report) shares fell 0.5% on Thursday . The stock traded as low as €56.90 ($59.89) and last traded at €56.90 ($59.89). 107,944 shares were traded during trading, an increase of 14% from the average session volume of 94,405 shares. The stock had previously closed at €57.20 ($60.21).

Carl Zeiss Meditec Price Performance

The company has a current ratio of 3.51, a quick ratio of 2.47 and a debt-to-equity ratio of 6.74. The company has a market capitalization of $4.89 billion, a price-to-earnings ratio of 24.96, a P/E/G ratio of 2.83 and a beta of 0.98. The firm has a 50-day simple moving average of €61.54 and a two-hundred day simple moving average of €68.70.

About Carl Zeiss Meditec

(Get Free Report)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

See Also

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.